Aspirin for the Primary Prevention of Cardiovascular Disease – Represented in NEJM by the ASPREE and ASCEND trials (and in Lancet by the ARRIVE trial).
1 September 2019 (11:23 - 11:46)
Organised by:
Slides
About the speaker
Monash University, Melbourne (Australia)
2 More presentations in this session
Professor C. Rapezzi (Ferrara, IT)
Access the full session
The Event
ESC Congress 2019
1 September 2019
11:23 CET
/f/125658/600x337/b583acaa94/ett_s3-ep4.png)
/f/125658/640x360/7735304567/ett-s3-ep12.jpg)
